Laura Francis Sells 10,048 Shares of SI-BONE, Inc. (NASDAQ:SIBN) Stock

SI-BONE, Inc. (NASDAQ:SIBN) CEO Laura Francis sold 10,048 shares of the business’s stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $12.58, for a total value of $126,403.84. Following the completion of the sale, the chief executive officer now owns 482,875 shares in the company, valued at $6,074,567.50. This represents a 2.04 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

SI-BONE Stock Performance

SIBN stock traded down $0.17 during midday trading on Wednesday, hitting $12.15. 217,144 shares of the stock traded hands, compared to its average volume of 392,037. The stock’s fifty day simple moving average is $13.91 and its 200-day simple moving average is $14.26. The firm has a market cap of $509.57 million, a P/E ratio of -13.39 and a beta of 1.22. SI-BONE, Inc. has a 1-year low of $11.76 and a 1-year high of $21.70. The company has a debt-to-equity ratio of 0.22, a current ratio of 8.25 and a quick ratio of 7.22.

Wall Street Analyst Weigh In

Several brokerages have issued reports on SIBN. Morgan Stanley dropped their target price on SI-BONE from $21.00 to $19.00 and set an “overweight” rating for the company in a research report on Tuesday, August 6th. Truist Financial boosted their target price on shares of SI-BONE from $16.00 to $18.00 and gave the company a “buy” rating in a research note on Wednesday, November 13th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $19.00 target price on shares of SI-BONE in a research report on Wednesday. Six investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, SI-BONE currently has an average rating of “Buy” and an average price target of $23.00.

Institutional Investors Weigh In On SI-BONE

Several institutional investors have recently bought and sold shares of SIBN. Harbor Capital Advisors Inc. raised its position in shares of SI-BONE by 440.5% during the 2nd quarter. Harbor Capital Advisors Inc. now owns 192,380 shares of the company’s stock valued at $2,487,000 after buying an additional 156,790 shares during the period. Silvercrest Asset Management Group LLC raised its holdings in SI-BONE by 13.8% in the first quarter. Silvercrest Asset Management Group LLC now owns 1,060,937 shares of the company’s stock valued at $17,368,000 after acquiring an additional 128,702 shares in the last quarter. Vanguard Group Inc. lifted its stake in SI-BONE by 1.8% in the first quarter. Vanguard Group Inc. now owns 2,463,501 shares of the company’s stock worth $40,328,000 after acquiring an additional 43,670 shares during the last quarter. American Century Companies Inc. increased its position in shares of SI-BONE by 22.8% in the 2nd quarter. American Century Companies Inc. now owns 1,986,476 shares of the company’s stock valued at $25,685,000 after purchasing an additional 368,637 shares during the last quarter. Finally, Divisadero Street Capital Management LP purchased a new stake in shares of SI-BONE during the 2nd quarter worth $1,552,000. 98.11% of the stock is currently owned by institutional investors and hedge funds.

SI-BONE Company Profile

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.